Enhancing GLP-1 levels through dietary or probiotic strategies may offer a promising approach for managing metabolic diseases such as type 2 diabetes, obesity, and cardiovascular conditions. The gene discussed is GCG; the disease is obesity due to melanocortin 4 receptor deficiency.